337 related articles for article (PubMed ID: 33711310)
1. Endothelial Nitric Oxide Synthase-Deficient Mice: A Model of Spontaneous Cerebral Small-Vessel Disease.
Liao FF; Lin G; Chen X; Chen L; Zheng W; Raghow R; Zhou FM; Shih AY; Tan XL
Am J Pathol; 2021 Nov; 191(11):1932-1945. PubMed ID: 33711310
[TBL] [Abstract][Full Text] [Related]
2. Pericyte-derived bone morphogenetic protein 4 underlies white matter damage after chronic hypoperfusion.
Uemura MT; Ihara M; Maki T; Nakagomi T; Kaji S; Uemura K; Matsuyama T; Kalaria RN; Kinoshita A; Takahashi R
Brain Pathol; 2018 Jul; 28(4):521-535. PubMed ID: 28470822
[TBL] [Abstract][Full Text] [Related]
3. White matter damage as a consequence of vascular dysfunction in a spontaneous mouse model of chronic mild chronic hypoperfusion with eNOS deficiency.
Chen X; Chen L; Lin G; Wang Z; Kodali MC; Li M; Chen H; Lebovitz SG; Ortyl TC; Li L; Ismael S; Singh P; Malik KU; Ishrat T; Zhou FM; Zheng W; Liao FF
Mol Psychiatry; 2022 Nov; 27(11):4754-4769. PubMed ID: 35948662
[TBL] [Abstract][Full Text] [Related]
4. Endothelial BACE1 Impairs Cerebral Small Vessels via Tight Junctions and eNOS.
Zhou H; Gao F; Yang X; Lin T; Li Z; Wang Q; Yao Y; Li L; Ding X; Shi K; Liu Q; Bao H; Long Z; Wu Z; Vassar R; Cheng X; Li R; Shen Y
Circ Res; 2022 Apr; 130(9):1321-1341. PubMed ID: 35382554
[TBL] [Abstract][Full Text] [Related]
5. Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion.
Edrissi H; Schock SC; Cadonic R; Hakim AM; Thompson CS
Brain Res; 2016 Sep; 1646():494-503. PubMed ID: 27350079
[TBL] [Abstract][Full Text] [Related]
6. Partial eNOS deficiency causes spontaneous thrombotic cerebral infarction, amyloid angiopathy and cognitive impairment.
Tan XL; Xue YQ; Ma T; Wang X; Li JJ; Lan L; Malik KU; McDonald MP; Dopico AM; Liao FF
Mol Neurodegener; 2015 Jun; 10():24. PubMed ID: 26104027
[TBL] [Abstract][Full Text] [Related]
7. Hypertension-Induced Cerebral Small Vessel Disease Leading to Cognitive Impairment.
Liu Y; Dong YH; Lyu PY; Chen WH; Li R
Chin Med J (Engl); 2018 Mar; 131(5):615-619. PubMed ID: 29483399
[TBL] [Abstract][Full Text] [Related]
8. The Spectrum of Cerebral Small Vessel Disease: Emerging Pathophysiologic Constructs and Management Strategies.
Muir RT; Smith EE
Neurol Clin; 2024 Aug; 42(3):663-688. PubMed ID: 38937035
[TBL] [Abstract][Full Text] [Related]
9. Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats.
Schreiber S; Drukarch B; Garz C; Niklass S; Stanaszek L; Kropf S; Bueche C; Held F; Vielhaber S; Attems J; Reymann KG; Heinze HJ; Carare RO; Wilhelmus MM
J Alzheimers Dis; 2014; 42 Suppl 3():S205-15. PubMed ID: 24825568
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic oligodendrocyte precursor cell-derived VEGFA is associated with blood-brain barrier impairment.
Manukjan N; Majcher D; Leenders P; Caiment F; van Herwijnen M; Smeets HJ; Suidgeest E; van der Weerd L; Vanmierlo T; Jansen JFA; Backes WH; van Oostenbrugge RJ; Staals J; Fulton D; Ahmed Z; Blankesteijn WM; Foulquier S
Acta Neuropathol Commun; 2023 Aug; 11(1):128. PubMed ID: 37550790
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small vessel disease.
Kaiser D; Weise G; Möller K; Scheibe J; Pösel C; Baasch S; Gawlitza M; Lobsien D; Diederich K; Minnerup J; Kranz A; Boltze J; Wagner DC
Acta Neuropathol Commun; 2014 Dec; 2():169. PubMed ID: 25519173
[TBL] [Abstract][Full Text] [Related]
12. MYPT1
Chen J; Li CG; Yang LX; Qian Y; Zhu LW; Liu PY; Cao X; Wang Y; Zhu MS; Xu Y
Transl Stroke Res; 2024 Jun; 15(3):606-619. PubMed ID: 36843141
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier leakage in relation to white matter hyperintensity volume and cognition in small vessel disease and normal aging.
Zhang CE; Wong SM; Uiterwijk R; Backes WH; Jansen JFA; Jeukens CRLPN; van Oostenbrugge RJ; Staals J
Brain Imaging Behav; 2019 Apr; 13(2):389-395. PubMed ID: 29572621
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
Front Immunol; 2021; 12():803504. PubMed ID: 34956241
[TBL] [Abstract][Full Text] [Related]
15. Cerebral small vessel disease: A review.
Chojdak-Łukasiewicz J; Dziadkowiak E; Zimny A; Paradowski B
Adv Clin Exp Med; 2021 Mar; 30(3):349-356. PubMed ID: 33768739
[TBL] [Abstract][Full Text] [Related]
16. Cerebral small vessel disease: Recent advances and future directions.
Markus HS; de Leeuw FE
Int J Stroke; 2023 Jan; 18(1):4-14. PubMed ID: 36575578
[TBL] [Abstract][Full Text] [Related]
17. Cerebral Small Vessel Disease.
Li Q; Yang Y; Reis C; Tao T; Li W; Li X; Zhang JH
Cell Transplant; 2018 Dec; 27(12):1711-1722. PubMed ID: 30251566
[TBL] [Abstract][Full Text] [Related]
18. Roles of NG2 Glia in Cerebral Small Vessel Disease.
He Y; Li Z; Shi X; Ding J; Wang X
Neurosci Bull; 2023 Mar; 39(3):519-530. PubMed ID: 36401147
[TBL] [Abstract][Full Text] [Related]
19. [Hereditary cerebral small-vessel disease].
Nozaki H; Nishizawa M; Onodera O
Nihon Rinsho; 2013 Mar; 71(3):545-54. PubMed ID: 23631251
[TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier leakage is more widespread in patients with cerebral small vessel disease.
Zhang CE; Wong SM; van de Haar HJ; Staals J; Jansen JF; Jeukens CR; Hofman PA; van Oostenbrugge RJ; Backes WH
Neurology; 2017 Jan; 88(5):426-432. PubMed ID: 28031395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
